Marshall Wace
DERM icon

Marshall Wace’s Journey Medical DERM Stock Holding History

Marshall Wace’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$990K Buy
+139,843
New +$799K ﹤0.01% 2194
2026
Q1 		– Sell
-19,401
Closed -$150K – 3297
2025
Q4 		$150K Buy
+19,401
New +$152K ﹤0.01% 2649

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Marshall Wace's DERM Position: Q2 2026 in Review

Marshall Wace opened a new position in Journey Medical (DERM) in Q2 2026: 139,843 shares worth $990K. The stake represents ﹤0.01% of the portfolio and ranks #2194 among its holdings. This is a return to the name: Marshall Wace previously reported a position in DERM as recently as Q4 2025.

Marshall Wace first reported a position in DERM in Q4 2025 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Marshall Wace held 139,843 shares of Journey Medical worth $990K as of Q2 2026.
  • Journey Medical was a new Marshall Wace position in Q2 2026.
  • Journey Medical made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2194 holding.
  • Marshall Wace first reported a position in Journey Medical in Q4 2025 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.